JPRN-UMIN000002824已完成2 期
A phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable gallbladder cancer. - Combination therapy of gemcitabine and hyperthermia in unresectable gallbladder cancer.
Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine0 个研究点目标入组 30 人开始时间: 2009年12月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria in this study are as follows: 1. Interstitial pneumonitis, pulmonary fibrosis with radiological findings 2.Presence of uncontrolled diabetes, severe liver dysfunction, unstable angina, myocardial infarction within three months. 3.Presence of active severe infection 4.Pregnant, lactating women or women with suspected pregnancy. 5.Medical history of severe hypersensitivity. 6.Severe complications 7.Inappropriate patients for this study judged by the physicians.
研究者
相似试验
已完成
2 期
A Phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable pancreatic cancer.unresectable pancreatic cancerJPRN-UMIN000001221Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine18
已完成
2 期
A phase 2 study of combination therapy with gemcitabine and candesartan in patients with advanced or recurrent pancreatic cancerpancreatic cancerJPRN-UMIN000005580niversity of Tokyo, Department of Gastroenterology33
已完成
2 期
A phase 2 study of combination therapy with gemcitabine S-1 and leucovorin in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000010720The University of Tokyo Hospital49
已完成
1 期
A phase 1 study of combination therapy with gemcitabine S-1 and leucovorin in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000007556The University of Tokyo, Department of Gastroenterology18
已完成
1 期
A phase 1 study of combination therapy with gemcitabine and candesartan in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000002152niversity of Tokyo, Department of Gastroenterology24